News

Filter

Current filters:

Rare diseasesGlobal

Orphan drugs benefit from fast-track approval – but are they getting to patients?

Orphan drugs benefit from fast-track approval – but are they getting to patients?

11-07-2014

Here's our take on the week's top stories.

GlobalRare diseases

UCB launches online search for rare phenotypes

UCB launches online search for rare phenotypes

28-01-2014

Belgian drugmaker UCB (Euronext Brussels: UCB) has launched an online search to find rare phenotypes…

GeneticsGlobalPharmaceuticalRare diseasesResearchUCB

New report shows major increase in pharmaceutical R&D for neglected diseases

16-01-2013

R&D, health system capacity-strengthening efforts, and medicine donations comprise the pharmaceutical…

GlobalPharmaceuticalRare diseasesResearchTropical diseases

Benlysta will be lupus market leader in 2021 with sales of more than $1.7 billion, says DR

25-10-2012

In the systemic lupus erythematosus (SLE) drug market, Human Genome Sciences/GlaxoSmithKline's (LSE:…

BenlystaBiotechnologyGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRare diseases

COMPANY SPOTLIGHT

Menarini

Back to top